543
Participants
Start Date
February 29, 2008
Primary Completion Date
October 31, 2008
ABT-335
135 mg capsule, daily, 12 weeks
placebo
placebo capsule, daily, 12 weeks
atorvastatin
40 mg, tablet, daily, 12 weeks
ezetimibe
10 mg capsule, daily, 12 weeks
Johnson City
Pittsburgh
Duncansville
Tipton
Jersey Shore
Newtown
Perkasie
Sellersville
Warminster
Melrose Park
Philadelphia
Philadelphia
Harleysville
Lansdale
Oxon Hill
Baltimore
Richmond
Virginia Beach
Norfolk
Roanoke
Statesville
Winston-Salem
Raleigh
Salisbury
Charlotte
Morehead City
Hickory
Summerville
Greenville
Anderson
Greer
Simpsonville
Suwanee
Roswell
Woodstock
Atlanta
Augusta
Holly Hill
New Smyrna Beach
Ormond Beach
Jacksonville
Jacksonville
Longwood
Pembroke Pines
Miami
Delray Beach
Tampa
Clearwater
Winter Haven
Fort Myers
Sarasota
Ocala
New Port Richey
Kissimmee
Hueytown
Columbiana
Birmingham
Tuscaloosa
Ozark
Nashville
Olive Branch
Louisville
Mount Sterling
Mogadore
Warren
Mason
Cincinnati
Indianapolis
Evansville
Evansville
Iowa City
Madison
Edina
Billings
Chicago
Chicago
Peoria
St Louis
St Louis
City of Saint Peters
Overland Park
Arkansas City
Wichita
Slidell
Hot Springs
Tulsa
Dallas
Fort Worth
Houston
San Antonio
Denver
Colorado Springs
Boise
West Jordan
Salt Lake City
Salt Lake City
Salt Lake City
Sierra Vista
Las Vegas
Los Angeles
Norwalk
Long Beach
Long Beach
West Hills
Santa Ana
Tustin
Concord
Carmichael
Roseville
Sacramento
Hillsboro
Spokane
Brockton
Berlin
Elizabeth
Hillsborough
Trenton
Cumberland
Lead Sponsor
Abbott
INDUSTRY